TrialInvestigative radiology2015

Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter study.

Thomas Lauenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.